PIK3C2A and COVID-19: Overall, no significant changes in any of the serological biomarkers analyzed before and after COVID-19 were identified, except for CPK levels (p = 0.03): CPK levels were significantly higher after the acute SARS-CoV-2 infection (mean difference: 41.0, 95%CI 10.1 to 71.8).